Thiem D Phan

Array ( [id] => 5938061 [patent_doc_number] => 20110213145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners' [patent_app_type] => utility [patent_app_number] => 13/089530 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 49901 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213145.pdf [firstpage_image] =>[orig_patent_app_number] => 13089530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660334 [patent_doc_number] => 20130041163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'PRODUCTION OF ATORVASTATIN LOW IN LACTONE IMPURITIES' [patent_app_type] => utility [patent_app_number] => 13/642258 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2331 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660333 [patent_doc_number] => 20130041162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'PRODUCTION OF ATORVASTATIN LOW IN ETHER IMPURITIES' [patent_app_type] => utility [patent_app_number] => 13/642005 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3308 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10851267 [patent_doc_number] => 08877949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Furo[3,2-g]chromene compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/642421 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19654 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435710 [patent_doc_number] => 08283479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'CXCR2 inhibitors' [patent_app_type] => utility [patent_app_number] => 13/079522 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52270 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13079522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733389 [patent_doc_number] => 20120015909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'MAO-B INHIBITORS USEFUL FOR TREATING OBESITY' [patent_app_type] => utility [patent_app_number] => 13/076174 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59188 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015909.pdf [firstpage_image] =>[orig_patent_app_number] => 13076174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8964212 [patent_doc_number] => 20130203815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'CYTOKINE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/637755 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19345 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869445 [patent_doc_number] => 08957216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Heterocyclic compounds useful for kinase inhibition' [patent_app_type] => utility [patent_app_number] => 13/636298 [patent_app_country] => US [patent_app_date] => 2011-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26212 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244994 [patent_doc_number] => 08202911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Migrastatin analog compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/053161 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 64510 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202911.pdf [firstpage_image] =>[orig_patent_app_number] => 13053161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413832 [patent_doc_number] => 08697869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => '3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators' [patent_app_type] => utility [patent_app_number] => 13/637005 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20637 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9524361 [patent_doc_number] => 08748632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Positive allosteric modulators of group II mGluRs' [patent_app_type] => utility [patent_app_number] => 13/051798 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31487 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13051798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140871 [patent_doc_number] => 20120094983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'ACYCLIC IKUR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/047998 [patent_app_country] => US [patent_app_date] => 2011-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32706 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094983.pdf [firstpage_image] =>[orig_patent_app_number] => 13047998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102647 [patent_doc_number] => 20110166140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'NOVEL SULPHONYLPYRROLES' [patent_app_type] => utility [patent_app_number] => 13/046936 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28639 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166140.pdf [firstpage_image] =>[orig_patent_app_number] => 13046936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540612 [patent_doc_number] => 08058455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Compound signamycin, method for production thereof, and use thereof' [patent_app_type] => utility [patent_app_number] => 13/033133 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8487 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058455.pdf [firstpage_image] =>[orig_patent_app_number] => 13033133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214198 [patent_doc_number] => 20110136820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Heterocyclic Compounds as CCR2 Antagonists' [patent_app_type] => utility [patent_app_number] => 13/018783 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68550 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136820.pdf [firstpage_image] =>[orig_patent_app_number] => 13018783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187146 [patent_doc_number] => 20110124900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'DIARYL ALKYLPHOSPHONATES AND METHODS FOR PREPARING SAME' [patent_app_type] => utility [patent_app_number] => 13/018940 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6372 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124900.pdf [firstpage_image] =>[orig_patent_app_number] => 13018940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324612 [patent_doc_number] => 20120197028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'Crosslinked Polymers with the Crosslinker as Therapeutic For Sustained Release' [patent_app_type] => utility [patent_app_number] => 13/017287 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6610 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13017287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757517 [patent_doc_number] => 20120029207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Novel Crystalline Form of Atorvastatin Hemi-calcium Salt, Hydrate Thereof, And Method of Producing The Same' [patent_app_type] => utility [patent_app_number] => 13/012385 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3826 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029207.pdf [firstpage_image] =>[orig_patent_app_number] => 13012385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490326 [patent_doc_number] => 20120289732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'PROCESS FOR THE ACTIVATION OF DOUBLE METAL CYANIDE CATALYSTS FOR THE PREPARATION OF POLYETHER CARBONATE POLYOLS' [patent_app_type] => utility [patent_app_number] => 13/574146 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11559 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8484041 [patent_doc_number] => 20120283448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'METHOD FOR PRODUCING 3,4-DISUBSTITUTED PYRROLIDINE DERIVATIVE AND PRODUCTION INTERMEDIATE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/520875 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13208 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520875 [rel_patent_id] =>[rel_patent_doc_number] =>)